Two women cannot have a genetically shared baby using bone marrow today. The idea has roots in real laboratory findings, where researchers coaxed bone marrow stem cells into expressing markers of early sperm-like cells, but no human pregnancy has ever resulted from this technique. The science behind it is more nuanced than the viral headlines suggest, involving several distinct lines of stem cell research that are often conflated into a single, oversimplified story.
Where the Bone Marrow Idea Comes From
The claim that bone marrow could let two women reproduce together traces back to a handful of experiments in the mid-2000s and beyond. Researchers found that human fetal bone marrow stem cells, when cultured under specific conditions, could be pushed toward expressing markers associated with early male germ cells. These cells turned on genes tied to sperm development, which led to excited press coverage suggesting that women’s bone marrow could be turned into functional sperm.1Reproductive BioMedicine Online. Derivation of male germ cell-like lineage from human fetal bone marrow stem cells
There is a critical gap between expressing genetic markers and actually producing a working sperm cell, though. Expressing early germ-cell genes is a bit like a stem cell putting on a costume: it looks the part at a molecular level, but it has not gone through the elaborate choreography of meiosis, the cell division process that halves the chromosome count and shuffles genetic material. No team has produced a mature, functional human sperm cell from bone marrow stem cells that could fertilize an egg and develop into a healthy embryo.
A separate line of work has shown that bone marrow-derived mesenchymal stem cells can support existing reproductive tissue. In hamsters rendered infertile by chemotherapy, transplanted bone marrow stem cells helped restore sperm production in the testes, with treated animals showing normal tissue structure and sperm appearing in the reproductive tract.2PubMed Central. Induction of Spermatogenesis by Bone Marrow-derived Mesenchymal Stem Cells in Busulfan-induced Azoospermia in Hamster That result is about repairing damaged male reproductive tissue, not about generating sperm from a female body. But it added to the public impression that bone marrow and reproduction are closely linked.
Bone Marrow Stem Cells and Ovarian Repair
One area where bone marrow stem cells have shown more clinically relevant promise is in supporting ovarian function. Women who experience premature ovarian failure, often after chemotherapy, lose the ability to produce mature eggs. Bone marrow mesenchymal stem cell transplantation has been studied as a way to revive dormant follicles and restore some ovarian reserve. In animal models, this approach improved ovarian blood supply, reduced cell death, and even led to spontaneous pregnancies in mice whose ovarian function had been chemically damaged.3PubMed. Fertility rescue and ovarian follicle growth promotion by bone marrow stem cell infusion
A small number of clinical cases have been reported where women with premature ovarian failure underwent bone marrow stem cell transplantation and went on to recover menstrual cycles and, in some instances, give birth. These early clinical reports are promising but remain far from routine.4PubMed Central. The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure The mechanism appears to be primarily about healing and nourishing the existing ovarian environment rather than generating brand-new eggs from scratch. In other words, bone marrow stem cells are acting as repair crews for damaged tissue, not as raw material for building gametes.
Two-Mother Mice and What They Actually Show
The strongest proof of concept for same-sex mammalian reproduction comes not from bone marrow work but from a different branch of stem cell science. In 2018, a team at the Chinese Academy of Sciences produced live mice from two mothers using haploid embryonic stem cells with targeted genetic edits. By deleting three specific imprinted regions in parthenogenetic haploid stem cells and injecting those cells into normal eggs, they created bimaternal pups that grew to adulthood with normal fertility. The corrected litter size of these bimaternal mice was comparable to that of naturally bred females.5Cell Stem Cell. Generation of Bimaternal and Bipaternal Mice from Hypomethylated Haploid ESCs with Imprinted Region Deletions
The same team also produced bipaternal mice, from two fathers, but those animals required far more extensive genetic editing (seven imprinted region deletions instead of three) and died shortly after birth. The contrast is telling: two-mother reproduction was dramatically more feasible than two-father reproduction, at least in mice, because the genomic imprinting barriers were simpler to overcome.
These experiments did not use bone marrow at all. They relied on specially engineered haploid embryonic stem cells, a technology that is conceptually distinct from anything involving bone marrow-derived cells. But news coverage often blurred the lines between different stem cell approaches, leaving many people with the impression that bone marrow itself was the key ingredient.
The Genomic Imprinting Problem
Mammals have a built-in barrier against same-sex reproduction called genomic imprinting. Certain genes are chemically tagged to work differently depending on whether they came from the mother or the father. An embryo needs one copy of these imprinted genes silenced in the maternal pattern and another in the paternal pattern. When both copies carry the same parental signature, development goes wrong: organs form abnormally, growth is stunted, or the embryo fails entirely.
The Chinese mouse experiments showed that you can get around this barrier by surgically deleting the problematic imprinted regions from the genome of one of the two contributing cells. With three such deletions, the bimaternal mouse pups were healthy and fertile. But about 14% of transferred embryos made it to live birth, meaning the process was still inefficient even under the best conditions.5Cell Stem Cell. Generation of Bimaternal and Bipaternal Mice from Hypomethylated Haploid ESCs with Imprinted Region Deletions When fewer deletions were made, the outcomes were grimmer: pups born with only one or two imprinted region deletions showed severe growth problems and died shortly after birth.
Human imprinting is considerably more complex than mouse imprinting. We share many of the same imprinted genes, but the regulatory landscape around them differs. No one knows exactly how many edits would be needed in human cells to replicate what was done in mice, or whether the edits that worked in mice would have the same effect in people. This is one of the biggest unsolved questions in the field.
Would All the Babies Be Girls?
This is one of the most common follow-up questions. Since biological females carry two X chromosomes and no Y chromosome, any gamete derived from a female body would carry an X. If both contributing parents are XX, every possible combination of their sex chromosomes produces XX offspring. There is no source of a Y chromosome in the equation, so all children born this way would be genetically female.
For some prospective parents, this is a neutral fact. For others, it raises questions about whether the technology could ever be extended. In theory, if stem cell-derived gametes could be produced from male cells as well, two men could potentially contribute to offspring, but the scientific barriers there are even higher. The 2018 mouse experiments showed bipaternal pups required more than twice as many genetic edits as bimaternal ones and still did not survive. The asymmetry exists because mammalian development is skewed toward needing a maternal genomic contribution in specific ways that cannot easily be replaced.
From Stem Cells to Functional Eggs Without Bone Marrow
A separate and more advanced line of research has focused on generating functional eggs entirely from pluripotent stem cells, bypassing bone marrow altogether. Japanese researchers developed a method to differentiate mouse embryonic stem cells into both primordial germ cell-like cells and the ovarian support cells those germ cells need in order to mature. When combined in culture, the germ cells entered meiosis, produced functional oocytes, and those oocytes, after fertilization, developed into live offspring.6PubMed. Generation of ovarian follicles from mouse pluripotent stem cells
This work represents the state of the art for creating gametes from stem cells. The approach uses induced pluripotent stem cells (iPSCs), which can be made from virtually any adult cell type, including skin or blood cells. In principle, a skin cell from one woman could be reprogrammed into a pluripotent state, differentiated into an egg, and fertilized with a naturally produced egg from her partner, but “in principle” is doing enormous lifting in that sentence. The process has only been completed in mice, and the efficiency and safety profile in humans remain unknown.
Researchers have also explored generating functional oocytes through polar body genome transfer, a technique where the genetic material from a polar body (a small cell that is normally discarded during egg maturation) is placed into a donor egg cytoplasm. This has been demonstrated with human cells, producing blastocysts at a reduced but meaningful rate compared to controls.7Cell Stem Cell. Functional Human Oocytes Generated by Transfer of Polar Body Genomes While this particular technique still requires sperm for fertilization, it demonstrates that the cellular machinery for creating viable human eggs from unconventional sources is getting more tractable.
Safety Concerns That Keep This in the Lab
Even if the technical barriers to making sperm or eggs from a woman’s bone marrow or other cells were overcome tomorrow, the safety questions would keep the technology far from a fertility clinic. Cells that are reprogrammed to a pluripotent state and then pushed down a new developmental pathway carry risks of uncontrolled growth, including tumor formation. Induced pluripotent stem cells, which would likely be the starting material for any future same-sex reproduction technology, have a documented concern around unwanted differentiation and potential for malignant transformation.8PubMed Central. Ethical and Safety Issues of Stem Cell-Based Therapy
Beyond cancer risk in the cells themselves, there are deep concerns about what happens to the offspring. Reprogramming a cell’s identity involves wholesale changes to its epigenetic marks, the chemical tags on DNA that control which genes are active. Even subtle errors in these marks can cause developmental problems, metabolic disorders, or issues that might not appear until adulthood. Research on mitochondrial DNA heteroplasmy has shown that even small variations in organelle genetics can shape embryo metabolism and cell fitness, adding another layer of complexity.9Cell Metabolism. Wild-Type Mitochondrial DNA Heteroplasmy Senses and Shapes Mito-Nuclear Interactions, Cellular Metabolism, and Pluripotency Any clinical application would need to demonstrate, over years of animal studies, that offspring are healthy not just at birth but across their lifespans and possibly into the next generation.
The perfection of both gamete derivation techniques and cell reprogramming methods remains a prerequisite before any human application could be considered.10PubMed. Using stem cell-derived gametes for same-sex reproduction: an alternative scenario Deriving sperm cells from female cells is considered especially challenging, and some researchers have described it as potentially impossible given current understanding of how sex-specific differentiation works.
What Female Couples Can Do Right Now
While the stem cell route remains experimental, female couples already have established reproductive options. The most common approach is donor insemination, using sperm from a known or anonymous donor to fertilize one partner’s egg. A variation gaining popularity in some countries is reciprocal IVF, commercially known as the ROPA method (Reception of Oocytes from Partner). In this approach, one woman provides the eggs and the other carries the pregnancy, giving both partners a biological connection to the child, though only one is genetically related.
A systematic review of ROPA outcomes found that in the largest case series, the cumulative live birth rate per couple was about 60%, with one comparative study showing higher live birth rates per transfer for ROPA than for standard IVF cycles.11PubMed Central. Lesbian shared IVF: the ROPA method: a systematic review ROPA is available in countries where the legal framework supports it, though access varies widely. It does not make both partners genetic parents of the same child, which is what stem cell-derived gamete technology would theoretically enable.
Public Attitudes and the Road to Regulation
Even when the science catches up, social acceptance and legal frameworks will shape whether stem cell-derived gametes are ever used for same-sex reproduction. A survey of public attitudes in Japan found that more than half of respondents supported the reproductive use of gametes derived from induced pluripotent stem cells for infertile heterosexual married couples, but the majority opposed the same use by unmarried or same-sex individuals.12PubMed Central. Public attitudes in Japan toward the reproductive use of gametes derived from human-induced pluripotent stem cells That gap between acceptance for heterosexual infertility treatment and acceptance for same-sex reproduction is likely to influence how regulators in different countries approach the technology.
Stakeholder research has found that diverse groups, including prospective parents, clinicians, and ethicists, express hope that in vitro gametogenesis could improve reproductive success rates and promote social inclusion, but frame their concerns primarily around equity and safety.13Stem Cell Reports. Anticipating in vitro gametogenesis: Hopes and concerns for IVG among diverse stakeholders The equity worry is straightforward: if creating gametes from stem cells requires years of laboratory work per patient and cutting-edge gene editing, the cost could make it available only to the wealthiest prospective parents, at least initially. Assisted reproduction is already expensive and unevenly covered by insurance in most countries, and a technology far more complex than conventional IVF would start at an even higher price point.
Most countries currently lack specific regulations governing stem cell-derived gametes. Existing rules around embryo research, gene editing, and assisted reproduction would apply in patchwork fashion. In the United Kingdom, for example, research involving human embryos is regulated up to 14 days of development, but there is no specific framework for embryos created from artificial gametes. In the United States, federal funding restrictions on embryo research and the lack of a national regulatory body for assisted reproduction create additional uncertainty. Any path to clinical use would require navigating regulatory landscapes that were designed before the technology existed.
The Difference Between Haploid Stem Cells and Bone Marrow
The persistent public association between bone marrow and same-sex reproduction is, at this point, something of a historical accident. The early bone marrow experiments attracted attention because they were dramatic and easy to summarize in a headline. But the actual scientific frontier has moved to induced pluripotent stem cells and haploid embryonic stem cells, neither of which requires bone marrow as a starting material.
Haploid embryonic stem cells, which carry only one set of chromosomes instead of the usual two, have shown germline competence in mice, functioning essentially as artificial gametes. It was this technology, not bone marrow, that enabled the birth of bimaternal and bipaternal mouse pups.14PubMed. Assisted Same-Sex Reproduction: The Promise of Haploid Stem Cells? The induced pluripotent stem cell route is similarly distinct: you would take a skin cell or blood cell, reprogram it to a pluripotent state, and then guide it toward becoming an egg or sperm precursor. Bone marrow might serve as a source of starting cells for reprogramming, but so could a cheek swab. The marrow itself is not the magic ingredient.
If you encounter claims that two women can already have a biological child together through bone marrow transplantation, treat them with heavy skepticism. The research that generated those headlines showed that bone marrow stem cells could turn on some of the right genetic switches in a dish. No one has produced a functional human sperm cell from bone marrow, let alone used one to create a pregnancy. The more promising paths to same-sex genetic parenthood involve technologies that are conceptually and practically distinct from anything bone marrow-related, and even those paths remain years or decades from clinical reality.